| Name | 4-hydroxy-2-methyl-5-nitro-1H-pyrimidin-6-one |
|---|---|
| Synonyms |
2-methyl-4,6-dihydroxy-5-nitropyrimidine
PYR096 4,6-dihydroxy-5-nitro-2-methylpyrimidine 5-nitro-4,6-dihydroxy-2-methylpyrimidine 4,6-dihydroxy-2-methyl-5-nitropyrimidine 2-METHYL-5-NITRO-PYRIMIDINE-4,6-DIOL |
| Density | 1.84g/cm3 |
|---|---|
| Boiling Point | 285.3ºC at 760mmHg |
| Melting Point | 270-280ºC |
| Molecular Formula | C5H5N3O4 |
| Molecular Weight | 171.11100 |
| Flash Point | 126.3ºC |
| Exact Mass | 171.02800 |
| PSA | 112.06000 |
| LogP | 0.62760 |
| Index of Refraction | 1.709 |
| HS Code | 2933599090 |
|---|
|
~%
53925-27-2 |
| Literature: Deninno, Michael P.; Wright, Stephen W.; Etienne, John B.; Olson, Thanh V.; Rocke, Benjamin N.; Corbett, Jeffrey W.; Kung, Daniel W.; Dirico, Kenneth J.; Andrews, Kim M.; Millham, Michele L.; Parker, Janice C.; Esler, William; Van Volkenburg, Maria; Boyer, David D.; Houseknecht, Karen L.; Doran, Shawn D. Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 17 p. 5721 - 5726 |
|
~%
53925-27-2 |
| Literature: DuPont Pharmaceuticals Company Patent: US6342503 B1, 2002 ; Location in patent: Example 101 ; US 6342503 B1 |
|
~85%
53925-27-2 |
| Literature: Beck, James P.; Arvanitis, Argyrios G.; Curry, Matt A.; Rescinito, Joseph T.; Fitzgerald, Larry W.; Gilligan, Paul J.; Zaczek, Robert; Trainor, George L. Bioorganic and Medicinal Chemistry Letters, 1999 , vol. 9, # 7 p. 967 - 972 |
| Precursor 3 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |